Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-705498 with or without fluticasone propionate in allergic rhinitis
2011-000115-11Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SB-705498 in allergic rhinitis (AR) (4 arms), sponsored by GSK. Primary endpoint: Total Nasal Symptom Score and individual symptom components at Day 8. Started Mar 2011; status: completed.
02
Drugs
SB-705498
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2011-000115-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000115-11.